Womens Health

GLP-1 Medications and Hypothyroidism: What Women Need to Know

If you're one of the millions of women living with hypothyroidism, you know how frustrating weight management can be. Even with thyroid medication, those extra pounds often feel impossible to lose. Now, with GLP-1 medications gaining attention for weight loss, you might be wondering: are these treatments safe if you have a thyroid condition?

The short answer is that for most people with hypothyroidism, GLP-1 medications can be used safely and effectively. However, there are important considerations, especially regarding certain types of thyroid conditions. Let's explore what you need to know.

Understanding the Connection Between Hypothyroidism and Weight

Hypothyroidism occurs when your thyroid gland doesn't produce enough thyroid hormone, slowing down your metabolism. This can lead to weight gain, fatigue, and difficulty losing weight even with diet and exercise.

Women are significantly more likely to develop hypothyroidism than men, with approximately one in eight women experiencing thyroid problems during their lifetime. The condition becomes even more common after age 60, though many women notice symptoms during their 30s, 40s, and 50s.

Even when thyroid levels are optimized with medication like levothyroxine, many people still struggle with weight. This is where GLP-1 medications may offer additional support.

What Are GLP-1 Medications?

GLP-1 receptor agonists, including semaglutide and tirzepatide, are medications originally developed for type 2 diabetes that have proven highly effective for weight loss. They work by mimicking a natural hormone that regulates appetite, slows digestion, and helps control blood sugar levels.

These medications help you feel fuller longer, reduce cravings, and make it easier to maintain a calorie deficit without the constant struggle of hunger.

Can You Take GLP-1 Medications With Hypothyroidism?

For most people with standard hypothyroidism, GLP-1 medications are considered safe. If you're taking levothyroxine or similar thyroid replacement therapy, there's typically no contraindication to starting a GLP-1 medication.

However, there's one critical exception you need to know about.

The Medullary Thyroid Cancer Consideration

GLP-1 medications carry a black box warning regarding a rare type of thyroid cancer called medullary thyroid carcinoma (MTC). In animal studies, these medications were associated with thyroid tumors in rodents.

You should not take GLP-1 medications if you have:

It's important to note that this type of thyroid cancer is very rare, accounting for only about 4% of all thyroid cancers. Standard hypothyroidism, even autoimmune hypothyroidism like Hashimoto's thyroiditis, is not a contraindication to GLP-1 therapy.

Important Interactions and Monitoring

Thyroid Medication Absorption

Because GLP-1 medications slow stomach emptying, there's a theoretical concern that they could affect how your body absorbs thyroid medication. While this hasn't been shown to be a significant clinical issue, your doctor may want to monitor your thyroid levels more closely when you start GLP-1 therapy.

If you notice symptoms of hypothyroidism returning—such as increased fatigue, weight gain despite the GLP-1, or feeling cold—let your doctor know. A simple blood test can check if your thyroid medication needs adjustment.

Weight Loss and Thyroid Dose Adjustments

As you lose weight on GLP-1 medication, your thyroid hormone needs may change. Some people require less thyroid medication as they lose weight, while others need the same dose. Regular monitoring ensures your levels stay optimal throughout your weight loss journey.

Special Considerations for Women

Women face unique challenges when managing both hypothyroidism and weight. Hormonal fluctuations during menstrual cycles, perimenopause, and menopause can affect both thyroid function and weight.

Many women find that even with well-controlled thyroid levels, the metabolic changes of perimenopause make weight loss particularly difficult. GLP-1 medications can be especially helpful during this transition, providing additional metabolic support when hormonal changes are working against you.

While men can also have hypothyroidism and benefit from GLP-1 therapy, the condition is five to eight times more common in women, making this intersection of conditions particularly relevant to women's health.

What to Discuss With Your Doctor

Before starting a GLP-1 medication with hypothyroidism, make sure to discuss:

Your doctor should review your medical history carefully and may order baseline thyroid labs before starting therapy. Ongoing monitoring typically includes checking thyroid levels every few months, especially during the initial weight loss phase.

The Bottom Line

For most women with hypothyroidism, GLP-1 medications represent a safe and effective option for weight management. The exception is for those with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

Working with a knowledgeable healthcare provider who understands both thyroid management and GLP-1 therapy ensures you receive comprehensive, personalized care. With proper monitoring and support, you can safely pursue your weight loss goals while managing your thyroid condition.

From the Ozari Care Team

If you have hypothyroidism and are considering GLP-1 therapy, ensure your most recent TSH and thyroid function tests are available for review. We recommend checking thyroid levels at baseline and again 8-12 weeks after starting treatment, then as needed based on symptoms. Don't hesitate to reach out if you experience any changes in your typical hypothyroid symptoms during treatment.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 28, 2026